Geert Bossche's Email & Phone Number

💼 Past Experience

Geert Vanden Bossche, PhD, DVM has a background in research with emphasis on vaccine development and quality assurance. He has conducted research in the field of rotavirus and has experience in vaccine development and quality assurance. While working at DZIF, Vanden Bossche was responsible for developing new vaccines for rotavirus, and he also enjoys working with yeast systems and human cells. Vanden Bossche also has experience in VARECO, where he was managing director from September 2012 to January 2019. While at VARECO, Vanden Bossche was responsible for developing new vaccines for rotavirus, as well as quality assurance for products. Vanden Bossche is also a Senior Program Officer at Global Health at the Bill and Melinda Gates Foundation, where he was responsible for developing new vaccines for rotavirus, human cells, and yeast systems.

🎓 Education

Geert Vanden Bossche, PhD, DVM, has a doctorate in Veterinary Medicine from the University of Gent. Afterward, he worked as a lecturer and research associate at the University of Saint-Luc in Belgium. He then moved to the University of Calgary in Canada, where he worked until he was appointed as a fellow in 2006. In 2012, he was appointed as a professor at the University of Calgary. Since then, he has been studying bite wounds and their response to veterinary treatment. The main focus of his research is how to improve the healing process of bite wounds.

💡 Technical & Interpersonal Skills

Geert Vanden Bossche, PhD, DVM, is a scientific doctor with a doctorate in Veterinary Medicine and Veterinary Practice and a Vetinformatics doctor.Before his current position at the German Centre for Infection Research (DZIF), Vanden Bossche was a Head of the Vaccine Development Office at the Bill and Melinda Gates Foundation (BMGF). Vanden Bossche was responsible for all aspects of the company's vaccine development, including the design, development and evaluation of new vaccines, as well as their orphan drugs programs. He also played a major role in developing GSK's vaccine development infrastructure. Vanden Bossche also held a number of other key positions within the vaccine industry, including Managing Director at VaReCo, from September 2012 to January 2019, and acting Chief Innovation & Scientific Officer at Univac from November 2014 to November 2016. He also served as Program Manager at Global Alliance for Vaccines and Immunisation (GAVI) from March 2015 to March 2016.After his years of experience in the vaccine development world, Vanden Bossche's current position at the German Centre for Infection Research (DZIF) is a Head of the Vaccine Development Office. He is responsible for all aspects of the vaccine development process, from design to development and evaluation of new vaccines. He is also in charge of the company's orphan drug programs and the development of new vaccine technologies. Vanden Bossche also played a major role in developing the company's infrastructure, including Lead Scientist at VaReCo and Acting Chief Innovation & Scientific Officer at Univac. Vanden Bossche has also many years of experience in QC-QA for vaccine development, which he applied to his current position at DZIF.